Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan with Autologous Stem Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin Lymphoma
Resource Type
Article
Authors
Nieto, Yago ; Thall, Peter F. ; Ma, Junsheng ; Valdez, Benigno C. ; Ahmed, Sairah ; Anderlini, Paolo ; Popat, Uday ; Jones, Roy B. ; Shpall, Elizabeth J. ; Hosing, Chitra ; Qazilbash, Muzaffar ; Kebriaei, Partow ; Alousi, Amin ; Timmons, Melissa ; Gulbis, Alison ; Myers, Alan ; Oki, Yasuhiro ; Fanale, Michelle ; Dabaja, Bouthaina ; Pinnix, Chelsea ; Milgrom, Sarah ; Champlin, Richard ; Andersson, Borje S.
Source
In Biology of Blood and Marrow Transplantation August 2018 24(8):1602-1609
Subject
Language
ISSN
1083-8791